Notre Dame researchers develop first-ever public database of nationwide opioid transactions
The weight of the opioid crisis is heavy. From 2006 to 2019 over one hundred metric tons of prescription opioid pain relievers – roughly the weight of a loaded Boeing 757-200 aircraft, were dispensed to individuals across the state of Indiana. Widespread opioid use is leading to devastating socioeconomic and health challenges, but organizations and policymakers working to fix the problem have not had a clear picture of opioid manufacture and travel. Now, a first-of-its-kind public database developed by researchers at the University of Notre Dame is revealing new details by enabling public access to over ten years of national controlled substance transaction information.
The database was created to store The Automation of Reports and Consolidated Orders System (ARCOS), a collection of over 550 million detailed opioid transactions from 2006 to 2019 that were submitted to the Drug Enforcement Administration (DEA) by manufacturers and distributors of controlled substances.
Providing an efficient way for policymakers and health professionals to acquire the data was a high priority for Notre Dame alumnus, Paul Ferrell Jr. ‘94, a lead attorney in the National Prescription Opiate Litigation, where the ARCOS data served as a key piece of evidence.
Researchers from across campus collaborated with Ferrell to develop a website where the records could be stored for public use. William Evans, Keough-Hesburgh Professor of Economics and co-founder of the Wilson Sheehan Lab for Economic Opportunities (LEO), and Ethan Leiber, Gilbert F. Schaefer Associate Professor and director of graduate studies in the Department of Economics, partnered with the Lucy Family Institute for Data & Society’s Applied Analytics & Emerging Technology Lab (AETL) to facilitate the design and development of the new platform, ARCOS.nd.edu, which launched in late 2023.
William Evans, Keough-Hesburgh Professor of Economics and co-founder of LEO, notes how the opioid crisis has been particularly devastating for those in poverty. “Understanding the root of the drug crisis is crucial for medical professionals, researchers, and policymakers to mitigate its impact effectively. This is critical as this crisis has been particularly devastating for certain groups such as those who have been left behind in the economy. With this data, we now have unbelievable detail about the origins of this crisis and we hope that this information can be part of developing solutions.”
The website offers customizable queries that trace the journey of individual prescription opioid purchases from the state and county of manufacture, to distribution within communities where they are dispensed.
Michael Kennel, lead software solutions architect with AETL, developed the user interface for ARCOS. He hopes that access to the data on ARCOS.nd.edu will provide insights into understanding the rise of opioid misuse in America. “The opioid crisis has claimed millions of lives. To change that, researchers need an easier way to obtain and analyze the data behind the crisis,” he said.
Nitesh Chawla, founding director of the Lucy Family Institute for Data & Society, and Frank M. Freimann Professor of Computer Science and Engineering, notes that the project’s goal to provide a use-oriented access to substance abuse transaction data aligns with Notre Dame’s goal of pursuing research that provides discoveries to enhance human well-being. He describes the opioid epidemic as “one of society’s wicked problems.”
“Addressing this challenge is central to the mission of the Lucy Family Institute and is aligned with the University’s strategic framework,” Chawla said. “The data itself is not going to save a life, but the results from our collective research using the data can provide impactful data innovations that promote the prosperity of humanity. We are grateful for this collaboration with LEO, as it truly is a story of domain-informed data-driven research for societal impact”
This effort also informs a larger data platform initiative being launched by AETL this year which "aims to scale impact by reducing barriers to access data and leverage advanced machine learning resources," said Rick Johnson, Managing Director of AETL.
The website will expand as more information is collected to include additional years. In anticipation of this, the AETL team is continuing to optimize the user experience by developing enhanced query tools and file export options. Kennel explains that “at AETL, the apps that we build may not necessarily have an immediate impact on someone's life, but we're enabling people to do things that will have that kind of lasting impact.”
To learn more about future AETL project collaborations, please visit the Lucy Family Institute website.
Contact:
Christine Grashorn, Communications Specialist
Notre Dame Research / University of Notre Dame
cgrashor@nd.edu / 574.631.4856
research.nd.edu / @UNDResearch
About the Lucy Family Institute for Data & Society
Guided by Notre Dame’s Mission, the Lucy Family Institute adventurously collaborates on advancing data-driven convergence research, translational solutions, and education to ethically address society’s wicked problems. As an innovative nexus of academia, industry, and the public, the Institute also fosters data science access to strengthen diverse and inclusive capacity building within communities. Our vision is to become the preeminent intellectual beacon, inspiring collaborative, equitable, and impactful data innovations as a global force for good.
About the Wilson Sheehan Lab for Economic Opportunities
Notre Dame’s Wilson Sheehan Lab for Economic Opportunities (LEO) helps service providers apply scientific evaluation methods to better understand and share effective poverty interventions. LEO matches top researchers with passionate leaders in the social service sector to conduct impact evaluations that identify innovative, effective, and scalable programs and policies that help people move permanently out of poverty. At LEO, we believe rigorous research is a powerful means to an end. An end to injustice. An end to dependence. An end to poverty. And a new beginning for millions of families who are ready to thrive.
Latest Research
- From reaction to resolution: The future of allergy treatmentTwelve-year-old Lauren Eglite was thrilled to attend a Notre Dame football game with her father, Erik, in 2017, even though her acute peanut allergy demands constant vigilance. She was even more excited when the stadium’s brand-new video board aired an NBC Fighting…
- New Study Highlights Mother-Child Link for Anemia in The GambiaAnemia is a "silent epidemic." It affects nearly 2 billion people globally, yet many people ignore its symptoms. Typically caused by the consumption of iron-deficient foods, anemia develops gradually. Its symptoms—such as fatigue, weakness, and shortness of breath—are frequently dismissed or misattributed.
- Megan McDermott joins ND–IBM Tech Ethics Lab as new Notre Dame directorThe Notre Dame–IBM Technology Ethics Lab, a critical component of the Institute for Ethics and the Common Good (ECG) and the Notre…
- Jenkins Center for Virtue Ethics receives grant to advance love-based ethical frameworkThe University of Notre Dame has received a $10 million grant from the John Templeton Foundation to support a project titled Love and Social Transformation: Empowering Scholars and Social Innovators to Develop the Love Ethic.
- ND-GAIN releases latest Country Index updateThe lastest update to the University of Notre Dame’s Global Adaptation Initiative's (ND-GAIN) Country Index is now live. The ND-GAIN team will release a second Country Index update in late Fall, which includes…
- In sub-Saharan Africa, 1 in 6 cancer medications found to be defectiveSerious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.